Nucleic acid based therapies: developing frontier for precision medicine. (2018)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmj.k223
PubMed Identifier: 29363539
Publication URI: http://europepmc.org/abstract/MED/29363539
Type: Journal Article/Review
Volume: 360
Parent Publication: BMJ (Clinical research ed.)
ISSN: 0959-8138